Holmusk, a global digital health and data analytics company headquartered in Singapore, will present GlycoLeap, a digital diabetes management programme, at the World Innovation Summit for Health (WISH) in Doha, Qatar.

The Innovation Showcases Gallery at WISH will feature some of the world's most exciting healthcare innovations, ranging from practical devices to business models and design-based solutions, said a statement.

The event will be held on November 29 and 30 at the Qatar National Convention Center.

GlycoLeap uses concepts from behavioural science to drive positive health outcomes for people with diabetes. Through small and sustainable lifestyle changes, users can achieve moderate weight loss and improve glucose control (as measured by HbA1c) within six months of the GlycoLeap programme.

GlycoLeap is a smart coach for type 2 diabetes that you can access anytime, anywhere. It provides you with the support you need to reach your health goals in less time, such as better glucose control, a healthier weight, and keeping up with exercise and diet changes. We combine human expert coaching with smart technology - all from your smartphone.
 
"This is a great opportunity for us to show our novel approach to improving care and outcomes for people with chronic disease," said Nawal Roy, CEO and founder of Holmusk. "It has been great working with the WISH team in the run up to the event and we are looking forward to meeting potential collaborators and partners through the WISH network." - TradeArabia News Service